Microbiome-driven carcinogenesis in colorectal cancer: Models and mechanisms

scientific article published on 31 October 2016

Microbiome-driven carcinogenesis in colorectal cancer: Models and mechanisms is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.FREERADBIOMED.2016.10.504
P8608Fatcat IDrelease_2ro2qo3i3ncthkbwvo6t3fbfui
P698PubMed publication ID27810411

P2093author name stringXingmin Wang
Yonghong Yang
Mark M Huycke
P921main subjectcolorectal carcinomaQ25493920
colorectal cancerQ188874
microbiomeQ1330402
carcinogenesisQ1637543
P304page(s)3-15
P577publication date2016-10-31
P1433published inFree Radical Biology and MedicineQ5500023
P1476titleMicrobiome-driven carcinogenesis in colorectal cancer: Models and mechanisms
P478volume105

Reverse relations

cites work (P2860)
Q52679521A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer.
Q98771133Abnormal Food Timing Promotes Alcohol-Associated Dysbiosis and Colon Carcinogenesis Pathways
Q37729161Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
Q89910578Caffeine and its main targets of colorectal cancer
Q55332933Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota.
Q91592710Comparison of Methods To Collect Fecal Samples for Microbiome Studies Using Whole-Genome Shotgun Metagenomic Sequencing
Q47321577Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
Q64071995Decoration of the enterococcal polysaccharide antigen EPA is essential for virulence, cell surface charge and interaction with effectors of the innate immune system
Q92031487Disparate cell proliferation and p53 overexpression in colonic crypts with normal epithelial lining found below the neoplastic canopy of conventional adenomas
Q64053007Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity
Q54123011Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade.
Q55333223Immunotherapy in colorectal cancer: for the select few or all?
Q33871520Insights into study design and statistical analyses in translational microbiome studies
Q55025271Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice.
Q46353300Mucosa-associated microbiota signature in colorectal cancer
Q60046972Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity
Q50100412Response to "Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Why the Search for an Infectious Etiology May Be Irrelevant".
Q58696404The Effects of Berberine on the Gut Microbiota in Apc Mice Fed with a High Fat Diet
Q55153904The coming of age: immunotherapy in gastrointestinal malignancies.

Search more.